Comparison Chart Acepodia, Inc.

Stocks

6976

KYG0073G1091

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 2026-07-31			5-day change	1st Jan Change
12.00 ^TWD	+0.42%		-6.61%	-21.82%

03-25	Acepodia, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-09	Biocytogen Pharmaceuticals Co., Ltd. and AcePodia Expand Collaboration Through Option-Based Evaluation Framework for First-In-Class Bispecific and Dual-Payload ADCs	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ACEPODIA, INC.	Other Biotechnology & Medical Research	+0.42%	-6.61%	-21.82%	-20.00%	-	217M	-	-	-